NIH Issues Draft of Guidelines Governing Stem Cell Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-The National Institutes of Health has proposed a set of guidelines aimed at ensuring the ethical and legal conduct of any embryonic and fetal stem cell research that it funds.

BETHESDA, Md—The National Institutes of Health has proposed a set of guidelines aimed at ensuring the ethical and legal conduct of any embryonic and fetal stem cell research that it funds.

The guidelines sanction research on cell lines from fetal tissue, work that develops new cells lines from fetal tissue, and research on cell lines privately derived from human embryos.

The guidelines prohibit studies that would create or contribute to a human embryo, combine human stem cells with an animal embryo, or engage in reproductive cloning of a human. Also barred are studies in which stem cells are derived using somatic cell nuclear transfer into a human or animal egg, and those in which stem cells are derived from human embryos created for

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content